

Description | Human Sequence CpG ODN (2006) Type B: 5" T*C*G*T*C*G*T*T*T*T*G*T*C*G*T*T*T*T*G*T*C*G*T*T 3"(* Indicates a phosphorothioate modification) Negative Control oligo: 5" TGCTGCTTTTGTGCTTTTGTGCTT 3" Functionality: This product is useful for the activation of TLR9 and the stimulation of TLR9 has been reported with 5-20 ug/ml. |
Specificity | CpG ODN (2006) with negative control oligo, TLR9 ligand (human) |
Dilutions |
| |
Application Notes | A TLR9/NF-kB SEAP reporter construct in a HEK 293 cell line was used as a model system for studying hTLR9 activation. | |
Reviewed Applications |
| |
Publications |
|